Successfully and safety use of dupilumab in the management of severe atopic dermatitis and concomitant moderate-to-severe hidradenitis suppurativa

MeSH terms

• Antibodies, Monoclonal
• Antibodies, Monoclonal, Humanized / adverse effects
• Dermatitis, Atopic* / diagnosis
• Dermatitis, Atopic* / drug therapy
• Double-Blind Method
• Hidradenitis Suppurativa* / diagnosis
• Hidradenitis Suppurativa* / drug therapy
• Humans
• Severity of Illness Index
• Treatment Outcome